1 North Wealth Services’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$348 Hold
14
﹤0.01% 303
2026
Q1
$196 Hold
14
﹤0.01% 266
2025
Q4
$157 Hold
14
﹤0.01% 276
2025
Q3
$162 Hold
14
﹤0.01% 254
2025
Q2
$171 Hold
14
﹤0.01% 259
2025
Q1
$201 Buy
+14
New +$219 ﹤0.01% 257
2019
Q4
$1K Hold
26
﹤0.01% 338
2019
Q3
$1K Buy
+26
New +$992 ﹤0.01% 307
2019
Q1
$1K Hold
26
﹤0.01% 288
2018
Q4
$1K Buy
+26
New +$1.36K ﹤0.01% 268

Other funds holding AVNS

1 North Wealth Services's AVNS Position: Q2 2026 in Review

1 North Wealth Services held its Avanos Medical (AVNS) position steady in Q2 2026 at 14 shares worth $348. The position accounts for ﹤0.01% of the portfolio, ranked #303.

1 North Wealth Services first reported a position in AVNS in Q4 2018 and has held it in 10 quarters since. The position peaked at $1K in Q4 2019. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • 1 North Wealth Services held 14 shares of Avanos Medical worth $348 as of Q2 2026.
  • 1 North Wealth Services left its Avanos Medical share count unchanged in Q2 2026.
  • Avanos Medical made up ﹤0.01% of 1 North Wealth Services's portfolio in Q2 2026, its #303 holding.
  • 1 North Wealth Services first reported a position in Avanos Medical in Q4 2018 and has held it in 10 quarters since.
  • 1 North Wealth Services's Avanos Medical position peaked at $1K in Q4 2019.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on 1 North Wealth Services's 13F filing for Q2 2026, filed 3 Aug 2026.